Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches.
Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches.
复制标题
DOI:
10.1016/j.ajhg.2022.04.001
复制
发表时间:
2022-05-05
影响因子:
9.8
通讯作者:
Burgess S
中科院分区:
文献类型:
--
作者:
Zuber V;Grinberg NF;Gill D;Manipur I;Slob EAW;Patel A;Wallace C;Burgess S
Mendelian randomization and colocalization are two statistical approaches that can be applied to summarized data from genome-wide association studies (GWASs) to understand relationships between traits and diseases. However, despite similarities in scope, they are different in their objectives, implementation, and interpretation, in part because they were developed to serve different scientific communities. Mendelian randomization assesses whether genetic predictors of an exposure are associated with the outcome and interprets an association as evidence that the exposure has a causal effect on the outcome, whereas colocalization assesses whether two traits are affected by the same or distinct causal variants. When considering genetic variants in a single genetic region, both approaches can be performed. While a positive colocalization finding typically implies a non-zero Mendelian randomization estimate, the reverse is not generally true: there are several scenarios which would lead to a non-zero Mendelian randomization estimate but lack evidence for colocalization. These include the existence of distinct but correlated causal variants for the exposure and outcome, which would violate the Mendelian randomization assumptions, and a lack of strong associations with the outcome. As colocalization was developed in the GWAS tradition, typically evidence for colocalization is concluded only when there is strong evidence for associations with both traits. In contrast, a non-zero estimate from Mendelian randomization can be obtained despite only nominally significant genetic associations with the outcome at the locus. In this review, we discuss how the two approaches can provide complementary information on potential therapeutic targets.
登录
查看更多内容
影响因子:
4.5
作者:
Baird DA;Liu JZ;Zheng J;Sieberts SK;Perumal T;Elsworth B;Richardson TG;Chen CY;Carrasquillo MM;Allen M;Reddy JS;De Jager PL;Ertekin-Taner N;Mangravite LM;Logsdon B;Estrada K;Haycock PC;Hemani G;Runz H;Smith GD;Gaunt TR;AMP-AD eQTL working group
通讯作者:
AMP-AD eQTL working group
DOI:
10.1136/bmj.j1648
发表时间:
2017-04-24
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Benn M;Nordestgaard BG;Frikke-Schmidt R;Tybjærg-Hansen A
通讯作者:
Tybjærg-Hansen A
DOI:
10.1097/ede.0000000000000161
发表时间:
2014-11
期刊:
Epidemiology (Cambridge, Mass.)
影响因子:
--
作者:
Burgess S;Davies NM;Thompson SG;EPIC-InterAct Consortium
通讯作者:
EPIC-InterAct Consortium
影响因子:
64.5
作者:
Astle, William J.;Elding, Heather;Soranzo, Nicole
通讯作者:
Soranzo, Nicole
影响因子:
7.7
作者:
Burgess, Stephen;Thompson, Simon G.
通讯作者:
Thompson, Simon G.